2011
DOI: 10.1016/j.biomaterials.2010.12.033
|View full text |Cite
|
Sign up to set email alerts
|

A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
232
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 213 publications
(244 citation statements)
references
References 29 publications
7
232
0
Order By: Relevance
“…Dowling and colleagues developed a chitosan-based amphiphilic biopolymer that exhibits clotting ability in the presence of blood by self-assembly that is readily reversible by introducing a sugar-based supramolecule [ 108 ] . First, chitosan was hydrophobically modifi ed by attaching a small number of hydrophobic tails to the backbone (hm-chitosan).…”
Section: Chitosan-based Sealantmentioning
confidence: 99%
“…Dowling and colleagues developed a chitosan-based amphiphilic biopolymer that exhibits clotting ability in the presence of blood by self-assembly that is readily reversible by introducing a sugar-based supramolecule [ 108 ] . First, chitosan was hydrophobically modifi ed by attaching a small number of hydrophobic tails to the backbone (hm-chitosan).…”
Section: Chitosan-based Sealantmentioning
confidence: 99%
“…On the other hand, Mo et al [71] developed a 16-arm polypropylenimine hexadecaamine dendrimer conjugated to a PEG derivative capped with hydrophobic oleoyl groups to accomplish rapid construction of multicellular structures of hepatic cells (figure 7). Lee et al [72] reported on hydrophobically modified chitosan (hm-chitosan) and its biomedical applications [73]. They applied hm-chitosan as a hemostatic agent and found that it coagulated blood even in the presence of heparin.…”
Section: Hydrophobic Interactionmentioning
confidence: 99%
“…For these reasons, heparin and heparan sulfate have been investigated as constituents for selfassembling nanoparticle delivery systems for growth factors and other drugs. Chitosan and heparin have both shown promise as particle constituents for wound healing applications [59,60]. In a recent study, Tang et al [58] prepared pH-responsive heparinized chitosan-poly(γ-glutamic acid) polyelectrolyte complex nanoparticles that encapsulated bFGF.…”
Section: Chitosan and Heparin-based Nanoparticles For Bfgf Deliverymentioning
confidence: 99%